Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD

Clinical trial NCT03725501 · COMPLETED

Trial details

NCT number: NCT03725501
Sponsor: AngioLab, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2018-12-07
Primary completion: 2021-06-22
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.